M. Albert

Journal of the American College of Cardiology · 2001–2019

A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Whom M. Albert trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. P. Ridker
  2. MR Stampfer

Who trusts M. Albert overall

  1. P. Ridker
  2. Peter Libby

Papers from M. Albert's perspective

Ordered by how strongly the researchers M. Albert trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial… (Journal of the American Medical Association (JAMA))
  2. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. (Circulation)
  3. Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (Journal of the American Pharmacists Association)
  4. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial… (European Heart Journal)
  5. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (Journal of the American Medical Association (JAMA))
  6. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
  7. Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein (Circulation)
  8. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. (Circulation)
  9. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (The Lancet)
  10. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention… (Circulation)

Their papers